Genmab enlists another antibody conjugate partner, teaming up with Bolt to develop up to 3 cancer programs

Big Danish biotech Genmab has signed on to a new collaboration, and it’s one both parties hope will tackle a broad swath of cancer indications.

Genmab is partnering with Bolt Biotherapeutics out of Redwood City, CA, to develop up to three new antibody-based conjugates in oncology. In the deal, Genmab...

Click to view original post